NDC 64764-515 - ADZYNMA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64764-515
- Package NDCs from labels
- 64764-515-50
- Manufacturer
- TAKEDA PHARMACEUTICALS AMERICA, INC. | Takeda Manufacturing Singapore Pte Ltd | Takeda Manufacturing Austria AG | SGS Lab Simon | BioReliance Ltd | Sigma-Aldrich Pte Ltd | Shire Human Genetic Therapies Inc. | Charles River Laboratories Germany GmbH | OFI Technologie & Innovation GmbH | Siegfried Hameln GmbH | Hameln RDS
- Effective date
- 2026-09-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ADZYNMA | TAKEDA PHARMACEUTICALS AMERICA, INC. | Takeda Manufacturing Singapore Pte Ltd | Takeda Manufacturing Austria AG | SGS Lab Simon | BioReliance Ltd | Sigma-Aldrich Pte Ltd | Shire Human Genetic Therapies Inc. | Charles River Laboratories Germany GmbH | OFI Technologie & Innovation GmbH | Siegfried Hameln GmbH | Hameln RDS | 2026-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
| VONVENDI | Takeda Pharmaceuticals America, Inc. | Baxalta US Inc. | Siegfried Hameln GmbH | Baxalta Manufacturing Sàrl | 2026-07-28 | PLASMA DERIVATIVE |
| ADYNOVATE | Takeda Pharmaceuticals Amercia, Inc. | BAXALTA US INC. | Siegfried Hameln GmbH | Takeda Manufacturing Austria AG | Baxalta Belgium Manufacturing SA | Baxalta Manufacturing Sàrl | Takeda Manufacturing Singapore Pte. Ltd. | 2026-05-28 | PLASMA DERIVATIVE |
| RIXUBIS | Takeda Pharmaceuticals America, Inc. | BAXALTA US INC. | Siegfried Hameln GmbH | Takeda Manufacturing Austria AG | Takeda Manufacturing Singapore Pte. Ltd. | OFI Technologie & Innovation GmbH | 2026-05-12 | PLASMA DERIVATIVE |
| CEPROTIN - Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | 2025-12-04 | PLASMA DERIVATIVE |
| Cinryze | Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Italia SPA | BAXALTA US INC. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | Prothya Biosolutions Belgium | Prothya Biosolutions Netherlands B.V. | 2025-11-28 | PLASMA DERIVATIVE |
| RECOMBINATE ® [Antihemophilic Factor (Recombinant)] | Takeda Pharmaceuticals America, Inc. | Baxalta US Inc. | 2025-04-03 | PLASMA DERIVATIVE |
| ADVATE | Takeda Pharmaceuticals America, Inc. | Baxalta US INC | Baxalta Manufacturing Sarl | Takeda Manufacturing Austria AG | Takeda Manufacturing Singapore Pte. Ltd. | Siegfried Hameln GmbH | 2025-04-03 | PLASMA DERIVATIVE |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64764-515 | CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CINRYZE (HUMAN C1-ESTERASE INHIBITOR) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 41 | Unmatched | 20241224_d53a911f-070d-498a-8a61-baab72b9d0fe.zip |
| 64764-515 | ADYNOVATE (ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED) KIT [TAKEDA PHARMACEUTICALS AMERCIA, INC.] | 22 | Unmatched | 20250331_ef290433-997f-4e98-86d6-42f6a99d6d18.zip |
| 64764-515 | RECOMBINATE (ANTIHEMOPHILIC FACTOR RECOMBINANT) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 21 | Unmatched | 20250426_d99348b1-edad-41de-aed9-903a6f9f279f.zip |
| 64764-515 | VONVENDI (VON WILLEBRAND FACTOR (RECOMBINANT)) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 17 | Unmatched | 20230418_53b6d198-6175-4a26-8606-dc0d2a0f12d6.zip |
| 64764-515 | CEPROTIN (PROTEIN C CONCENTRATE HUMAN) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 14 | Unmatched | 20250110_926914a9-78b2-40ea-b37d-2a55c09bf275.zip |
| 64764-515 | ADVATE (ANTIHEMOPHILIC FACTOR (RECOMBINANT)) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 13 | Unmatched | 20250418_80fa03d2-cd4c-4155-9b57-1396c4fa42da.zip |
| 64764-515 | RIXUBIS (COAGULATION FACTOR IX (RECOMBINANT)) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 13 | Unmatched | 20250410_f5070a92-96b8-476a-a2dc-18b22d95e5e0.zip |
| 64764-515 | ADZYNMA (APADAMTASE ALFA) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 6 | Unmatched | 20240831_22728e96-efa0-46c1-bdd1-ad89a796d5e3.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nauzene | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | a60660b2-c5db-45a0-885f-de93e655380d | 2025-04-29 | Warnings | B22547B95K |
| Sinus Wash Packet | SODIUM BICARBONATE, SODIUM CHLORIDE | BETTER LIVING BRANDS LLC | 33ee7b77-0871-4df8-e063-6394a90ac479 | 2025-04-29 | Warnings | 451W47IQ8X |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 6d43fa91-0940-437f-ba70-b2d3f977593e | 2025-04-25 | Warnings, Adverse reactions | 451W47IQ8X |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Camber Consumer Care Inc | b321a7f5-f80b-4a51-9fd9-2c21fc1cae9b | 2025-04-23 | Warnings | G2M7P15E5P |
| good neighbor pharmacy clearlax | POLYETHYLENE GLYCOL 3350 | Amerisource Bergen | e0b419b6-6ce0-4aaa-948f-dee5b2ec2082 | 2025-04-17 | Warnings | G2M7P15E5P |
| Nat Mur 6X | SODIUM CHLORIDE | Hyland's Inc. | dcf0e2ac-3b69-3ae4-e053-2a95a90aaf41 | 2025-04-10 | Warnings | 451W47IQ8X |
| Winco | POLYETHYLENE GLYCOL 3350 | WINCO FOODS | d649f758-a46f-4864-8718-878ee5a74bfc | 2025-04-10 | Warnings | G2M7P15E5P |
| Bestmade Natural Products BM68 Pellets | PHOSPHORUS, ARG NIT, GELSEMIUM, NAT MUR, KALI BROM, BARYTA CARB | Bestmade Natural Products | 32423a04-31d1-7477-e063-6394a90aecac | 2025-04-08 | Warnings | 451W47IQ8X |
| Bestmade Natural Products Nat Mur 8x | NATRUM MURIATICUM | Bestmade Natural Products | 31e0e16d-e4df-cd9a-e063-6394a90abcc1 | 2025-04-03 | Warnings | 451W47IQ8X |
| Eye Wash | WATER | CMC Group Inc. | 6158a1f5-a6bc-4a3e-9d1d-0a310d9dc561 | 2025-04-02 | Warnings | 059QF0KO0R |
| Kidneyforce-HP | ARNICA MONTANA, AURUM METALLICUM, CACTUS GRANDIFLORUS, CALCAREA CARBONICA, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, SOLIDAGO VIRGAUREA | BioActive Nutritional, Inc. | 0c0f0c0c-10c2-47eb-aad6-bbffb6e16799 | 2025-04-02 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE TABLET | Belleview Bioscience LLC | 31195e8f-d4de-9e37-e063-6294a90a4156 | 2025-03-24 | Warnings | 451W47IQ8X |
| Bestmade Natural Products BIO13 Lactose Free | CALC PHOS KALI SULPH, KALI PHOS, NAT MUR | Bestmade Natural Products | 303590c5-8a66-aafc-e063-6294a90a1a4e | 2025-03-23 | Warnings | 451W47IQ8X |
| Bestmade Natural Products BIO13 | CALC PHOS, KALI SULPH, KALI PHOS, NAT MUR | Bestmade Natural Products | 2fffab7f-0d4b-0e96-e063-6294a90a34d8 | 2025-03-23 | Warnings | 451W47IQ8X |
| Bestmade Natural Products Nat Mur | NAT MUR | Bestmade Natural Products | e9e9a4f6-5104-3c6f-e053-2995a90a1165 | 2025-03-21 | Warnings | 451W47IQ8X |
| Pituitary Liquescence | CAULOPHYLLUM THALICTROIDES, HYPOPHYSIS SUIS, HYPOTHALAMUS SUIS, PINEAL GLAND (SUIS), CIMICIFUGA RACEMOSA, NATRUM MURIATICUM, CINCHONA OFFICINALIS, ADRENOCORTICOTROPHIN | Nutritional Specialties, Inc. | 292ca967-abe8-4ae1-b2fe-942531a1e14a | 2025-03-20 | Warnings | 451W47IQ8X |
| Anxiety HP | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, CALCAREA CARBONICA, IGNATIA AMARA, KALI CARBONICUM, LACHESIS MUTUS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STAPHYSAGRIA, STRAMONIUM | Energique, Inc. | 191393fa-5f36-43c0-a183-09258eef9bda | 2025-03-20 | Warnings | 451W47IQ8X |
| HYDRA NEB | SODIUM CHLORIDE | Venture Healthcare Ltd | 30b184bf-2451-d96b-e063-6294a90a43c7 | 2025-03-19 | Warnings | 451W47IQ8X |
| HYDRA NEB | SODIUM CHLORIDE | Laboratoire Unither | 30b244c0-84bb-a0a0-e063-6394a90a9dee | 2025-03-19 | Warnings | 451W47IQ8X |
| Polyethylene Gycol 3350 | POLYETHYLENE GYCOL 3350 | Allegiant Health | 13851c9a-a226-481b-9db5-bc7053997df7 | 2025-03-17 | Warnings | G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.